Jun 10, 2020
EpicentRx Appoints Life Sciences Investment Banking Veteran, Dr. Franck Brinkhaus, as President and Chief Financial Officer
Apr 02, 2020
Global TGF Beta Receptor Type 1 Pipeline Insights, 2020: Therapeutics Development & Assessment, Companies Involved, Drug Profiles, Dormant Products, Discontinued Products
Apr 01, 2020
Global Activin Receptor Type 1 Pipeline & Therapeutic Landscape Assessment, 2020
Mar 03, 2020
MAX BioPharma Announces Key Update to its Liver Fibrosis Program Showing Efficacy of an Oxysterol Lead Drug Candidate in Inhibiting NASH in a Humanized Mouse Model
Oct 31, 2019
Pliant Therapeutics to Present Preclinical Data in Primary Sclerosing Cholangitis at The Liver Meeting 2019
Jun 27, 2019
Pliant Therapeutics Reports Positive Results of Phase 1b Clinical Study Supporting Advancement of PLN-74809 for Treatment of Idiopathic Pulmonary Fibrosis
Mar 28, 2019
Pliant Therapeutics Presents Data in Human NASH Liver Tissue at The International Liver Congress 2019 Hosted by the European Association for the Study of the Liver (EASL)
Nov 09, 2018
Pliant Therapeutics Presents Preclinical Data in NASH and PSC at The Liver Meeting 2018
Sep 24, 2018
Study Reveals Protein Behind RDEB's Painful Symptoms and How Stem Cells Might Stop It
Apr 09, 2018
Supporting Cells in the Heart Contribute to Cardiac Disease
Oct 06, 2017
Sirnaomics Publishes Results Showing Dual Targeting of TGF-b1 and COX-2 Reduces Human Skin Hypertrophic Scar through Activation of Fibroblast Apoptosis